Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repligen Corp (NASDAQ:RGEN)

41.44
Delayed Data
As of 4:00pm ET
 -0.50 / -1.19%
Today’s Change
26.16
Today|||52-Week Range
46.81
+34.46%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close41.94
Today’s open41.36
Day’s range41.18 - 41.93
Volume143,438
Average volume (3 months)325,871
Market cap$1.6B
Dividend yield--
Data as of 4:00pm ET, 08/23/2017

Growth & Valuation

Earnings growth (last year)+21.43%
Earnings growth (this year)+34.47%
Earnings growth (next 5 years)+18.00%
Revenue growth (last year)+25.14%
P/E ratio81.3
Price/Sales10.05
Price/Book8.41

Competitors

 Today’s
change
Today’s
% change
ARRYArray Biopharma Inc+0.89+10.29%
MYOKMyoKardia Inc+0.35+0.80%
LXRXLexicon Pharmaceutic...-0.10-0.70%
CORTCorcept Therapeutics...+0.01+0.07%
Data as of 4:15pm ET, 08/23/2017

Financials

Next reporting dateNovember 2, 2017
EPS forecast (this quarter)$0.11
Annual revenue (last year)$104.5M
Annual profit (last year)$11.7M
Net profit margin11.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tony J. Hunt
Vice President-
Global Operations
Steve Curran
Corporate headquarters
Waltham, Massachusetts

Forecasts